In Latin America, healthcare provision continues to vary significantly.
Increasingly, improving access to this across the region means not only addressing general barriers, such as the lack of investment in more rural areas, but also identifying and targeting unique ones.
For instance, Latin America hosts an extremely diverse population. Improving healthcare outcomes requires clinicians and researchers to understand how genetic and lifestyle factors affect the likelihood of certain diseases or populations who are more at risk of certain illness.
The Economist Intelligence Unit recently published a report titled “Personalized Healthcare in Latin America: Universalising the Promise of Innovation,” which highlighted three emerging solutions that have been made possible thanks to innovation.
These include a growing ability to gather and store information in an integrated way due to electronic health records and health trackers, patient information at the molecular level –including the genetic profiles of individuals, pathogens, and tumors– and analytical tools to sift through this information to understand its medical relevance at the individual patient level.
Given this, digital tools that support healthcare providers in Latin America when working on these areas of opportunity are key.
In a bid to improve access to medical information in Latin America, Colombian-based company 360 Health Data has introduced a new platform known as Coralia Health. The platform uses AI and automated tools to translate medical resources and clinical studies into Spanish so that local clinicians can access key insights more easily and intuitively.
What Coralia Health means for Latin America
Founded in 2024 by a team of seasoned healthcare leaders with extensive and deep experience in Real World Evidence (RWE) and information technology, 360 Health Data is committed to transforming medical knowledge management.
By designing a comprehensive knowledge ecosystem, the company hopes to improve the healthcare industry by democratizing access to information.
“Improving access to clinical decision support tools in Spanish contributes to better decision-making, strengthens daily medical practice, and helps reduce health inequalities in Latin America,” Manuela Gutiérrez (article’s featured photo), Operations Leader at 360 Health Data, said in an interview.
“Coralia Health is designed specifically for Spanish-speaking physicians. We combine validated and curated content with artificial intelligence tools to offer relevant scientific knowledge in Spanish, adapted to clinical practice. More than a repository, we are a living ecosystem of collaboration and clinical intelligence,” Gutiérrez adds.
Unlocking the potential of personalized healthcare in Latin America requires require strong collaboration between stakeholders and the building blocks to support an ecosystem that tailors healthcare plans to the needs of the individual. Coralia Health represents one of these vital building blocks.
AI supporting clinical decision making
Although access to a Spanish-language knowledge ecosystem is the first priority, there are vast troves of information available to clinicians in the Coralia Health platform.
“For healthcare professionals, time is one of the most valuable resources. Spending hours searching multiple sources, validating the credibility of data, and trying to adapt findings from other parts of the world is a daily challenge,” according to Mike Hoey, co-founder of 360 Health Data.
In response to this, 360 Health Data created an AI-assistant, Salus, which is embedded into the platform. This makes it easier and less-time consuming to find cutting-edge data and real-world evidence (RWE) on disease, life science, and drug information in Spanish.
It’s also helping clinicians interact on the platform and through other popular channels such as WhatsApp and is set to fuel collaboration and engagement within the community.
Looking ahead, 360 Health Data is actively working to expand AI-based clinical capabilities, better integrate local regulatory data, launch specialized modules by medical specialty, and strengthen collaborative networks among healthcare professionals throughout Latin America.
Finally, the team hope to challenge inequalities associated with regional clinical data and Real World Evidence (RWE), historically used primarily by global pharmaceutical companies.
